About us
Simris Biologics is a wholly owned subsidiary of Simris Group.
We are harnessing deep cyanobacterial expertise and the world’s largest strain library to develop next-generation ADC payloads that unlock the full therapeutic potential of this promising cancer treatment class.
Name: Mr Jonathan Royce
Title: Managing Director
Name: Dr Heike Enke
Title: Chief Science Officer
Name: Dr Dan Enke
Title: Scientific Advisor